Rocket


News + Filings
Key Docs
Charts
Ownership
Insiders

 
 
AMARIN CORP PLC (AMRN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $1.70 Metrics
OS:
Market cap:
Net cash:
EV:

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)
Date FiledTypeDescription
04/29/2021 GN Amarin Reports First Quarter 2021 Financial Results and Provides Business Update
04/29/2021 GN Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel
04/22/2021 GN Amarin Receives Great Britain Marketing Authorization for VAZKEPA from the Medicines and Healthcare Products Regulatory Agency (MHRA) 1,2
04/20/2021 GN Amarin to Report First Quarter Results and Host Conference Call on April 29, 2021
04/17/2021 GN VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science a...
04/06/2021 GN Amarin Commences Commercial Initiatives for VAZKEPA in European Union Following Recent Regulatory Approval for Cardiovascular Risk Reduction Indication
03/17/2021 GN VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce Stroke in At-Risk Patients in Analyses of Landmark REDUCE-...


Financial Summary   (All financials)
No report was found.
Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy